Cohort profile: Evaluation of the Methods a nd Management of Acute Coronary Events (EMMACE) Longitudinal Cohort

Theresa Munyombwe,Tatendashe B. Dondo,Marlous Hall,Ramesh Nadarajah,Ben Hurdus,Suleman Aktaa,Mohammad Haris,Adam Keeley,Robert West,Alistair Hall,Paul Norman,Chris P. Gale

European heart journal. Quality of care & clinical outcomes（2023）

Cited 0|Views24

No score

Abstract

Aims The Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort study aims to investigate health trajectories of individuals following hospitalization for myocardial infarction (MI)............................................................................................................................................................................................. Methods and results EMMACE is a linked multicentre prospective cohort study of 14 899 patients with MI admitted to 77 hospitals in England who participated in the EMMACE-3 and -4 studies between 1st November 2011 and 24th June 2015. Long-term followup of the EMMACE cohorts was conducted through the EMMACE-XL (27th September 2020 to 31st March 2022) and EMMACE-XXL (1st July 2021 to 1st July 2023) studies. EMMACE collected individual participant data for health-related quality of life (HRQoL) measured by three-level EuroQol five-dimension and visual analogy scale at admission, 1 month, 6 months, 12 months, and 10 years follow-up, as well as medications, medication adherence, beliefs about medicines, Satisfaction with Information about Medicines Scale, and illness perceptions. Participant data were deterministically linked to the Myocardial Infarction National Audit Project (MINAP) for information on baseline treatments and comorbidities, Hospital Episode St atistics Admitted Patient Care (for cause-specific hospitalization data), and the Office for National Statistics (for mortality data) up to 2020............................................................................................................................................................................................. Conclusion EMMACE is a nationwide prospective cohort that will provide unique insights into fatal and non-fatal outcomes, medication adherence, and HRQoL following MI. Trial registration: ClinicalTrials.gov NCT01808027 and NCT01819103

Translated text

Key words

Myocardial infarction, Outcomes, Hospitalizations, Medications, Health-related quality of life, Cohort, Electronic health records, Longitudinal data

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined